{"0": "Sphingolipid metabolism integrated pathway", "1": "Sphingolipid metabolism overview", "2": "Sphingolipid pathway", "3": "Electron transport chain oxphos system in mitochondria", "4": "Sphingolipid metabolism in senescence", "5": "Overlap between signal transduction pathways contributing to lmna laminopathies", "6": "Metapathway biotransformation phase i and ii", "7": "Mitochondrial complex iv assembly", "8": "Nonalcoholic fatty liver disease", "9": "Ciliopathies", "10": "Mitochondrial complex i assembly model oxphos system", "11": "Alzheimers disease", "12": "Allograft rejection", "13": "Alzheimers disease and mirna effects", "14": "Cholesterol metabolism with bloch and kandutschrussell pathways", "15": "Oxidative phosphorylation", "16": "Myometrial relaxation and contraction pathways", "17": "Network map of sarscov2 signaling pathway", "18": "Mitochondrial immune response to sarscov2", "19": "Pi3kakt signaling pathway", "20": "Interferon type i signaling pathways", "21": "Ras signaling", "22": "Fragile x syndrome", "23": "Initiation of transcription and translation elongation at the hiv1 ltr", "24": "Glycogen synthesis and degradation", "25": "Pancreatic adenocarcinoma pathway", "26": "Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells", "27": "Envelope proteins and their potential roles in edmd physiopathology", "28": "Pdgf pathway", "29": "Thymic stromal lymphopoietin tslp signaling pathway", "30": "Il3 signaling pathway", "31": "Il2 signaling pathway", "32": "Oncostatin m signaling pathway", "33": "Egfr tyrosine kinase inhibitor resistance", "34": "Follicle stimulating hormone fsh signaling pathway", "35": "Il9 signaling pathway", "36": "Glioblastoma signaling pathways", "37": "Leukocyteintrinsic hippo pathway functions", "38": "Epo receptor signaling", "39": "Fgfr3 signaling in chondrocyte proliferation and terminal differentiation", "40": "Nongenomic actions of 125 dihydroxyvitamin d3", "41": "Mirna regulation of prostate cancer signaling pathways"}